Alcaraz Surges to 57¢ to Reach US Open Final as Draw Collapses Around Him
Alcaraz surges to 57¢ to reach the 2026 US Open final as Sinner, Djokovic, and Auger-Aliassime all exit early. Market analysis and trade risks.
TL;DR - Alcaraz opened at 40¢ to reach the US Open final on Aug 31; six days later he sits at 57¢ after three convincing wins with improving margins each round. - The men's draw has done much of the heavy lifting: Sinner withdrew pre-tournament, Djokovic lost first round, and Auger-Aliassime fell in the second round. - Alcaraz's own post-match comments confirm no significant rust, and his head-to-head records favor him against every likely opponent remaining in his half. - The 24-hour price on the advance-to-Final contract slipped 4¢ even as Zverev's equivalent contract gained 11¢ — worth watching as the bracket tightens.
What the Market Says
At 57¢ YES and 43¢ NO, observed at 2026-09-06 11:22 UTC on Polymarket's "Will Carlos Alcaraz advance to the Final in Men's Singles at the 2026 US Open?" contract (resolving Sept 12), the market is pricing Alcaraz as a moderate favorite to make the final — not a lock, but comfortably ahead of even money.
Six days ago, this desk would have quoted you 40¢. On Aug 31, the morning after Alcaraz's first competitive singles match in four months, the market reflected genuine uncertainty: a seven-time Grand Slam champion returning from a wrist injury, rust unquantified, path potentially intersecting with Sinner. The +17¢ move since then is the market's running tally of everything that has gone right — both on his side of the court and off it.
The 24-hour volume on this contract reached $1,194 as traders repriced the semifinal path following the Wu Yibing win. One subtlety worth noting: the contract dipped 4¢ in the last 24 hours even as Zverev's equivalent climbed 11¢. That divergence suggests the market is not simply inflating all finalist probabilities — it is making a relative judgment about who is peaking and who might be running on fumes heading into the quarterfinals.
The Case
Carlos Alcaraz returned to tour on Aug 30 after 139 days away following a wrist injury sustained in April. His first match back — a straight-sets win over Safiullin — told the market something, but not much. First matches after injury layoffs are famously misleading in both directions.
The second match told more. Against Jaime Faria on Sept 3, Alcaraz dropped the opening set 4-6 before reeling off three sets at 6-0, 6-3, 6-2. Dropping a set is not ideal; winning the next three by a combined 18-5 is a fairly emphatic editorial response to concerns about sharpness.
The third match, against Wu Yibing on Sept 5, was the one that moved the contract. Alcaraz swept Wu 6-3, 6-4, 6-1, a scoreline that extended his Grand Slam winning streak to 17 consecutive matches. That is not an injury comeback — that is a champion operating at altitude. After the match, Alcaraz told reporters:
"To be honest, I'm better than I thought. Physically I thought I was going to be bad after the first match, but I am recovering really well. I am doing great things off the court to be in a good state. Right now, I think my level is really good. I think I have caught the rhythm of the competition."
Athletes say reassuring things after wins. But the score progression backs him up: the margin of each win has widened, not narrowed. That is the opposite of a player managing a lingering problem.
Then there is the draw, which has been notably cooperative. World No. 1 Jannik Sinner — the one player who, when healthy, represents the clearest ceiling on Alcaraz's tournament — never arrived, withdrawing with a knee injury before play began. Novak Djokovic, seeded No. 3 and theoretically still capable of deep runs on hard courts, lost in the first round to Mariano Navone. Felix Auger-Aliassime, seeded third in the draw, fell in the second round to Karen Khachanov. Three structural obstacles, gone before Alcaraz faced anyone ranked inside the top 30.
Looking at what remains: Alcaraz faces Tommy Paul in the fourth round, a player he has beaten six consecutive times. Beyond Paul, the most credible threats in his half are Ben Shelton (Alcaraz leads 3-0 head-to-head) and Daniil Medvedev (Alcaraz leads 6-3 lifetime). Neither record guarantees anything, but neither is the kind of matchup that justifies pricing Alcaraz below even money.
Alexander Zverev, priced at 56¢ to reach the final as of press time, sits in the opposite half and has already been dragged into five-set, late-night matches. If both Alcaraz and Zverev advance, a drained Zverev is a different proposition than a rested one. That is a problem for another contract.
Risks
The honest case for NO at 43¢ is not frivolous, and anyone sitting at 57¢ should hold these clearly in mind.
Medvedev is playing clean tennis. His straight-set record through the tournament suggests he is not the same player who has struggled on and off since 2024. He beat Alcaraz at Indian Wells in March 2026 — the most recent data point in that head-to-head, and a reminder that a 6-3 lifetime record is not a permanent force field. He has reached the US Open final before; Arthur Ashe Stadium is not a foreign venue for him.
The statistics behind the Wu win contain a yellow flag. Alcaraz posted a 67% first-serve success rate and accumulated 33 unforced errors against 21 winners in that match. Against Wu Yibing, that imbalance does not cost you the set. Against Medvedev or Shelton under pressure, it might. Four months off the tour is a long time, and the body's memory for competitive tension is different from its memory for practice-court mechanics.
Shelton has crowd equity. He is 0-3 against Alcaraz, but he has reached the US Open semifinal twice and plays in front of one of the loudest home crowds in tennis. The head-to-head does not neutralize Arthur Ashe on a night when Shelton is firing on serve. It just tilts the prior.
Stefanos Tsitsipas is resurgent. After dropping outside the top 80 earlier this year, he has won three consecutive matches at this tournament, including a 2-6, 6-1, 7-6, 6-1 win over Lehecka on Sept 5. He is not the name most traders are watching, which is precisely when players tend to do damage.
At 43¢, the NO position is pricing in a roughly two-in-five chance that at least one of these scenarios materializes. That is not an unreasonable number given the variables still in play. The contract resolves Sept 12 — six days from the capture timestamp — and a lot of tennis gets played in six days.
Prices captured at press time and are not live. Not financial advice. Independent publication - not affiliated with Polymarket, Banana Gun, or any venue.
Every price in this piece was captured 2026-09-06 11:22 UTC. Odds move; the analysis may not age with them. Not financial advice.